Thu, Aug 21, 2014, 8:46 AM EDT - U.S. Markets open in 44 mins.


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • thirdmeinvestor thirdmeinvestor Sep 13, 2013 11:44 PM Flag

    Updated estimate for revenues from Kalydeco

    For Year 2013 the revenue from K would be more like 400 M, not 278 M that I projected last December:;_ylt=AgQZMVXMdcUsRGSa5W6UauXeAohG;_ylu=X3oDMTB1bDNjNmEwBHBvcwM0BHNlYwNNZWRpYU1zZ0JvYXJkc1hIUlVsdA--;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&q=Conservative+revenue+estimate+from+Kalydeco&in=b&inf=&sm=&bn=55fbc366-e0be-363e-88ff-c35e56e44242&stb=r&sto=d&lv=e&f=12

    Label expansions into all gating and residual mutations will start in 2014, and I project the revenue from K would be 650 M in 2014. For 2015-2016 there will be a quantum jump from CF revenues as I indicated earlier.

91.30-0.62(-0.67%)Aug 20 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.